Armata Pharmaceuticals (ARMP) Free Cash Flow Growth (3y) (2016 - 2026)
Armata Pharmaceuticals (ARMP) Free Cash Flow Growth (3y) (2016 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
24.91% |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
20.11% |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
14.71% |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
Armata Pharmaceuticals |
275.44 Mn |
270.68 Mn |
- |
33.17% |
| Date | Value |
|---|
| Mar 31, 2026 |
33.17% |
| Dec 31, 2025 |
12.47% |
| Sep 30, 2025 |
26.91% |
| Jun 30, 2025 |
7.45% |
| Mar 31, 2025 |
-26.98% |
| Dec 31, 2024 |
3.83% |
| Sep 30, 2024 |
-18.39% |
| Jun 30, 2024 |
-34.60% |
| Mar 31, 2024 |
-23.35% |
| Dec 31, 2023 |
-16.36% |
| Sep 30, 2023 |
-49.36% |
| Jun 30, 2023 |
-43.82% |
| Mar 31, 2023 |
-65.29% |
| Dec 31, 2022 |
-53.93% |
| Sep 30, 2022 |
-37.20% |
| Jun 30, 2022 |
-15.97% |
| Mar 31, 2022 |
-12.98% |
| Dec 31, 2021 |
-35.02% |
| Sep 30, 2021 |
-36.62% |
| Jun 30, 2021 |
-36.14% |
